Ulrich Hutzschenreuter

Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line – Results from the prospective German TLK cohort study

Claus-Christoph Steffens, Corinna Elender, Ulrich Hutzschenreuter et al. · Lung Cancer · 2019 · 49 citations · Full text

Medicine, Oncology, Chemotherapy +12

Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms

Wolfgang Knauf, Ali Aldaoud, Ulrich Hutzschenreuter et al. · Annals of Hematology · 2018 · 34 citations · Full text

Medicine, Hematology, Oncology +13

Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma

Eva Herrmann, Norbert Marschner, Marc‐Oliver Grimm et al. · World Journal of Urology · 2011 · 26 citations

Medicine, Oncology, Pharmacology +14

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study

Norbert Marschner, Dirk Arnold, Erik Engel et al. · Clinical Epidemiology · 2015 · 22 citations · Full text

Medicine, Oncology, Pharmacology +11

Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project

Hans-Jürgen Hurtz, Hans Tesch, Thomas Göhler et al. · Breast Cancer Research and Treatment · 2017 · 22 citations · Full text

Medicine, Oncology, Breast Oncology +16